Diabete Type 2 Clinical Trial
Official title:
Effectiveness and Satisfaction of Insulin Therapy in Type 2 Diabetic Patients (Real Life Study)
NCT number | NCT06117449 |
Other study ID # | ESITT2DP |
Secondary ID | |
Status | Not yet recruiting |
Phase | |
First received | |
Last updated | |
Start date | April 1, 2024 |
Est. completion date | May 1, 2025 |
Diabetes mellitus is an endocrine disorder with heterogeneous etiologies, which is characterized by raised levels of glucose in a person's blood and disturbances of macromolecules such as carbohydrate, fat, and protein metabolism resulting from defects in insulin secretion, insulin action, or both. A lack of insulin, or the inability of cells to respond to it, leads to high levels of blood glucose (hyperglycemia), which is the clinical indicator of diabetes. Type 1 DM is characterized by insulin deficiency and a tendency to develop diabetic ketoacidosis, whereas type 2 DM is characterized by variable degrees of insulin resistance, impaired insulin secretion, and excessive hepatic glucose produc Tion. Diabetes is one of the most rapidly increasing chronic diseases and an important public health problem all over the world. The global burden of diabetes is rising dramatically worldwide. Type 2 diabetes is the most common type of diabetes, accounting for around 90% of all diabetes worldwide (IDF). The prevalence of type 2 diabetes is high and rising across all regions. This rise is driven by increasing life expectancy, economic development, and increasing urbanization leading to more sedentary lifestyles and greater consumption of unhealthy foods linked with obesity. Type 2 diabetes prevalence has increased in Egypt during the past few years. Egypt is one of the top ten nations with the greatest proportion of adults with diabetes, according to the International Diabetes Federation. In Egypt, the prevalence of diabetes was projected to be 9.6 million, with type 2 diabetes making up the bulk of cases .
Status | Not yet recruiting |
Enrollment | 100 |
Est. completion date | May 1, 2025 |
Est. primary completion date | April 1, 2025 |
Accepts healthy volunteers | |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: -Patients with type 2 diabetes mellitus aged =18 years. - Patients going on insulin therapy versus patients going on oral antidiabetic drugs. - patients included if they met the following Criteria: - previous diagnosis of diabetes mellitus or on medical therapy of DM. - no prescription fills for a basal insulin containing product in the 1-year pre index date period; and no prescription fills for bolus insulin or mixed insulin products on index date or in the 1-year pre-index date periods. Exclusion Criteria: - Patients had type 1 diabetes mellitus. - Pregnant patients. - Incapable of completing the study questionnaires. - were pregnant at any time during the pre-or post-index periods; or - were diagnosed with any other type of diabetes during the study period, including, gestational diabetes , secondary diabetes , or other abnormal glu-cose conditions . - Patients who were con-comitantly participating in another trial or receiving insulin treatment for reasons other than T2DM. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Assiut University |
Elsner RH. California bureaucrats propose control of excess physicians. Fed Bull. 1979 May;66(5):140-1. No abstract available. — View Citation
Ishii H, Terauchi Y, Jinnouchi H, Taketsuna M, Takeuchi M, Imaoka T. Effects of insulin changes on quality of life and glycemic control in Japanese patients with type 2 diabetes mellitus: The insulin-changing study intending to gain patients' insights into insulin treatment with patient-reported health outcomes in actual clinical treatments (INSIGHTs) study. J Diabetes Investig. 2013 Nov 27;4(6):560-70. doi: 10.1111/jdi.12086. Epub 2013 Apr 30. — View Citation
Witek TJ Jr. The nose as a target for adverse effects from the environment: applying advances in nasal physiologic measurements and mechanisms. Am J Ind Med. 1993 Nov;24(5):649-57. doi: 10.1002/ajim.4700240512. No abstract available. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | blood glucose level | comparison of blood glucose level on patients who going on insulin therapy with patient going on oral antidiabetic | baseline | |
Primary | HbA1C level | comparison of HbA1C level on patients who going on insulin therapy with patient going on oral antidiabetic | baseline |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04940962 -
Translational Study Using Human Abdominal Adipose Tissue Biopsies to Investigate the Role of Cannabinoid Receptor 1 (CB1) in Controlling Endocannabinoid and Adipokine Secretion
|
N/A | |
Completed |
NCT05359341 -
Which is Better to Start With DPP-4 Inhibitors or SGLT-2 Inhibitors in Egyptian Diabetic Patients?
|
N/A | |
Recruiting |
NCT04700813 -
Research Study for Rare Pathogenic Mutations Causing Type 2 Diabetes and Complications
|
||
Completed |
NCT05413330 -
Corticosteroid Injection Combined With Cataract Surgery in Diabetic Eyes.
|
Phase 2/Phase 3 | |
Recruiting |
NCT04927377 -
Accessible and Inclusive Diabetes Telecoaching Self-Management Program
|
N/A | |
Completed |
NCT05585268 -
Electronic Decision Support for Deprescribing in Patients on Hemodialysis
|
N/A | |
Active, not recruiting |
NCT05088616 -
Native American Diabetes Project
|
N/A | |
Not yet recruiting |
NCT03273738 -
Vascular and Metabolic Changes in Postmenopausal Diabetics
|
||
Active, not recruiting |
NCT04642911 -
Longterm Follow-up of Subjects With Diabetes 2 Type Treatment With ex Vivo Gene Therapy
|
||
Withdrawn |
NCT04283617 -
Reversibility of Brain Glucose Transport and Metabolism in T2DM: an Intervention Study
|
N/A | |
Recruiting |
NCT04769687 -
Symbiotics and Systemic Inflammation in Chronic Kidney Disease
|
Phase 2 | |
Withdrawn |
NCT06104358 -
Ph 2a Study of HU6 on Energy Metabolism, Muscle and Liver Substrate Metabolism, and Mitochondrial Function in Subjects Who Are Overweight or Obese With Type 2 Diabetes
|
Phase 2 | |
Recruiting |
NCT03341793 -
Impact of Changes in Muscle Secretome in the Remission of Type 2 Diabetes Mellitus Induced by Bariatric Surgery
|
N/A | |
Not yet recruiting |
NCT06080802 -
The Effect of Addition of Metformin to SGLT2 In Diabetic Patients With Heart Failure With Preserved Ejection Fraction
|
Phase 2/Phase 3 | |
Recruiting |
NCT04485845 -
Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression
|
Phase 4 | |
Recruiting |
NCT05050500 -
The Effect of Dapagliflozin on the Short-term Prognosis of Patients With Acute Myocardial Infarction
|
Phase 4 | |
Completed |
NCT04115657 -
The Effect of Different Starches of Boba Pearls and Sugar Substitutes Used in Milk Tea on Glycaemia, Insulinaemia and Appetite Control (Pearl Study)
|
N/A | |
Completed |
NCT06188572 -
The Effect of Peripheral Neuropathy Symptoms on Temporomandibular Joint Functionality
|
||
Completed |
NCT04120844 -
Effectiveness of Motivational Interviewing on Improving Care for Type 2 Diabetes Mellitus Patients in China
|
N/A | |
Completed |
NCT05789706 -
Use of a Smart-phone Based Medication Adherence Platform to Improve Outcomes in Uncontrolled Non-insulin Dependent Diabetes Among Veterans
|
N/A |